Authors: EGGLESTON A WIGERINCK A HUIJGHEBAERT S DUBOIS D HAYCOX A

Citation: A. Eggleston et al., COST-EFFECTIVENESS OF TREATMENT FOR GASTROESOPHAGEAL REFLUX DISEASE IN CLINICAL-PRACTICE - A CLINICAL DATABASE ANALYSIS, Gut, 42(1), 1998, pp. 13-16

Authors: EGGLESTON A WIGERINCK A HAYCOX A

Citation: A. Eggleston et al., OUTCOME RESEARCH IN GORD - RETROSPECTIVE ANALYSIS OF PRESCRIPTION DATA (MEDIPLUS(R) UK) ON CISAPRIDE (CIS), RANITIDINE (RAN) AND OMEPRAZOLE(OME), Gastroenterology, 112(4), 1997, pp. 13-13

Authors: EGGLESTON A WIGERINCK A HAYCOX A

Citation: A. Eggleston et al., COST OF GORD-MEDICATION IN CLINICAL-PRACTICE IN PATIENTS WITH A FIRSTDIAGNOSIS OF GORD BASED ON PRESCRIPTION-DATA ANALYSIS (MEDIPLUS UK), Gastroenterology, 112(4), 1997, pp. 13-13

Authors: CRABBE R GHOOS I DERIDDER F WIGERINCK A

Citation: R. Crabbe et al., CISAPRIDE NORMALIZES FAT-INDUCED GASTRIC-EMPTYING FOR SOLIDS IN HEALTHY-VOLUNTEERS, Gastroenterology, 112(4), 1997, pp. 716-716

Authors: BURETTE A GLUPCZYNSKI Y DEPREZ C DEKOSTER E URBAIN D VANDERAUWERA J WIGERINCK A DRNEC J

Citation: A. Burette et al., OMEPRAZOLE ALONE OR IN COMBINATION WITH CLARITHROMYCIN FOR ERADICATION OF H-PYLOR - RESULTS OF A RANDOMIZED DOUBLE-BLIND CONTROLLED-STUDY, Gastroenterology, 104(4), 1993, pp. 49-49